Deliverables

Work package 1: Programme management and coordination

Grant agreement, November 2016

Published: 01/03/2017

Deliverable 1.2 Establishment of Governing Board, August 2019

Published: 01/03/2017, Updated: 13/08/2019

Deliverable 1.8 Establishment of Stakeholder Forum and Advisory Board

Published: 27/09/2017

Deliverable 1.5 Legal and Ethics Policy Paper, September 2018

Published: 24/09/2018

Work package 2: Knowledge hub

Deliverable 2.5 2019 Strategy for the communication and dissemination of HBM4EU results, October 2018

Published: 15/11/2018

Deliverable 2.1 HBM4EU Website, March 2017

Published: 31/03/2017

Deliverable 2.2 Strategy for the communication and dissemination of HBM4EU results, March 2017

Published: 31/03/2017

Deliverable 2.3 2018 Strategy for the communication and dissemination of HBM4EU results

Published: 09/10/2017

Deliverable 2.4 2018 Programme of training activities, materials and capacity building mechanisms

Published: 27/11/2017

Deliverable 2.7 Online library: content and use, November 2018

Published: 02/11/2018

Deliverable 2.6 First review of training methods

Published: 12/03/2019

Deliverable 2.9 Summary report on helpdesk activities

Published: 05/08/2019

Work package 4: Prioritisation and input to the annual work plan

Deliverable 4.1 Template for the submission of rapid requests, May 2017

Published: 18/05/2017

Deliverable 4.2 Scoping documents on HBM4EU priority substances for 2018, June 2017

Deliverable 4.3 Prioritisation strategy and criteria

Published: 28/06/2017

Deliverable Report 4.4 - First report on the stakeholder consultation and the mapping of needs

Published: 08/08/2018

Deliverable 4.5 Second list of HBM4EU priority substances and Chemical Substance Group Leaders for 2019-2021

Published: 03/09/2018

Deliverable 4.6 Scoping documents for the second round priority substances

Published: 25/03/2019

Work package 5: Translation of results into policy

Deliverable 5.4 A (phased) plan for action: from Human Biomonitoring to targeted policy action - Report of Case Study 1 – phthalates and bisphenols

Published: 05/04/2019

Deliverable 5.5 Human biomonitoring in risk assessment: 2nd set of examples on the use of HBM in risk assessments of HBM4EU priority chemicals

Published: 09/07/2019

Deliverable 5.1 Human biomonitoring in risk assessment: analysis of the current practice and 1st examples on the use of HBM in risk assessments of HBM4EU priority chemicals

Published: 16/11/2017

Additional Deliverable 5.1 A (phased) plan for action: how structured multi-actor dialogues on human biomonitoring results can facilitate targeted policy action (generic canvas for HBM4EU)

Published: 07/12/2017

Deliverable 5.2 1st substance-group specific derivation of EU-wide health-based guidance values

Published: 01/02/2018

Deliverable 5.3 Scoping paper on the development of an indicator on chemical exposure in the European population

Published: 11/12/2017

Work package 6: Sustainability and capacity building

Deliverable 6.1 First set of key indicators for HBM4EU, June 2017

Published: 26/06/2017

Additional deliverable 6.1 Preliminary Report on different options for a sustainable EU HBM and feedback from different institutions

Published: 09/07/2019

Deliverable 6.3 Consultation on a sustainable HBM initiative in Europe

Published: 28/01/2019

Deliverable 6.2 Revised set of key indicators

Published: 13/08/2019

Deliverable 6.5 Sustainability of HBM4EU in the future and related operational architecture concept: first report

Published: 13/08/2019

Work package 7: Survey design and fieldwork preparation

Deliverable 7.1 Report on ongoing activities and existing data and data gaps for the 1st prioritised substances including a list of metadata that can be uploaded in IPCheM

Published: 19/12/2017

Deliverable 7.2 Strategy and SOPs for human sample exchange, including ethical demands

Published: 09/07/2019

Deliverable 7.3 1st prioritisation Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and sampling

Published: 07/11/2018

Deliverable 7.6 - 2nd prioritisation Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and sampling

Published: 08/05/2019

Deliverable 7.4 1st material for communication to participants, including informed consent

Published: 17/07/2018

Deliverable 7.5 Report on ongoing activities and existing data and data gaps for the 2nd prioritised substances

Published: 25/01/2019

Additional deliverable 7.2 Literature research and concept for a sample quality study on impact of thawing and freezing on integrity of human samples for selected 1st and 2nd priority substances

Published: 28/01/2019

Deliverable 7.7 - 2nd set of materials for communication to participants, including informed consent

Published: 10/04/2019

Work package 8: Targeted field work surveys and alignment at EU level

Additional deliverable 8.1 Report on access to occupational data

Published: 27/06/2017

Additional Deliverable AD 8.2 Research plan for chromates study under HBM4EU

Published: 03/01/2018

Deliverable 8.1 Description of the national programs A strategy to collect EU wide HBM data

Published: 05/07/2018  

Additional Deliverable - Cr fact sheets ; French, Finnish, German, Italian, Portuguese, Dutch and Polish

Published: 09/08/2018

Deliverable 8.3 First report on targeted new fieldwork study results

Published: 29/08/2018

Deliverable 8.4 Initial report on strategies adopted to align studies across Europe

Published: 03/09/2018

Deliverable 8.2 First report on biobank activities, August 2018

Published: 13/11/2018

Deliverable 8.5 Initial Report on Occupational Studies

Published: 05/04/2019

Work package 9: Laboratory analysis and quality assurance

Additional Deliverable 9.2 - Survey of tentative prices for biomarker analyses

Published: 12/04/2019

Deliverable 9.1 Criteria for the prioritisation of biomarkers, April 2017

Published: 27/04/2017

Deliverable 9.2 Prioritised list of biomarkers, matrices and analytical methods for the 1st prioritisation round of substances

Published: 15/09/2017

Deliverable 9.3 Database of candidate laboratories for the 1st prioritisation round of substances

Published: 14/03/2018

Deliverable 9.4 The Quality Assurance/Quality Control Scheme in the HBM4EU project

Published: 03/11/2017

Additional Deliverable 9.1 General guidance for new method development within HBM4EU and role of task 9.3 therein

Published: 17/07/2018

Deliverable 9.6 - Databases of candidate laboratories for the 2nd prioritisation round of substances

Published: 04/07/2019

Deliverable 9.5 - Prioritised list of biomarkers, matrices and analytical methods for the 2nd prioritisation round of substances

Published: 04/06/2019

Work package 10: Data management and analysis

Deliverable 10.1 Data Management Plan, July 2017

Published: 01/08/2017

Annex to Deliverable 10.1 Data Policy, July 2017

Published: 01/08/2017

Deliverable 10.2 Statistical Analysis Plan

Published: 03/01/2018

Deliverable 10.4 1st annual list of exposure distributions and/or European reference values

Published: 30/01/2019

Deliverable 10.5 Statistical Analysis Plan

Published: 01/03/2019

Work package 11: Linking HBM, health surveys and registers

Additional Deliverable 11.1 How can the results from BRIDGE Health be incorporated to the work of HBM4EU?

Published: 28/09/2017

Additional Deliverable 11.2 Criteria for feasibility studies

Published: 28/09/2017

Deliverable 11.1 Report on opportunities and obstacles of combining HBM and health studies, availability of health studies with biological samples, availability of administrative registers, and guidelines for combining HBM and health studies

Published: 29/06/2018

Deliverable 11.2 - Report on workshop about opportunities and obstacles for linking HBM and health studies

Published: 15/02/2019

Deliverable 11.3 - Report on opportunities and obstacles of combining HBM and health studies, availability of health studies with biological samples, availability of administrative registers, and guidelines for combining HBM and health studies for the 2nd prioritisation round of substances

Published: 12/06/2019

Additional Deliverable 11.3 Selection of feasibility studies for linking HBM and health studies, and linking to administrative data sources

Published: 10/01/2019

Work package 12: From HBM to exposure

Additional Deliverable 12.1 Database of exposure-related and ancillary data for priority substances

Published: 31/07/2017

Deliverable 12.2 Report on the optimal methodology for exposure reconstruction from HBM data

Published: 03/01/2018

Additional Deliverable 12.2 Roadmap for model PBTK/D model refinement and analysis for priority substances

Published: 02/08/2017

Deliverable 12.1 Review paper on PBTK/D models for the 1st set of priority compounds

Published: 12/12/2018

Deliverable 12.3 Biological half-life and internal dosimetry of the 1st set of priority compounds

Published: 28/01/2019

Additional deliverable 12.4 - Conceptual design of the integrated computational platform

Published: 15/02/2019

Additional Deliverable AD12.6 “Optimised algorithms for reverse dosimetry“

Published: 13/06/2019

Deliverable 12.4 Report on estimation of relevant tissue and biological fluid doses of 1st set of priority compounds in the EU population using refined PBTK modelling

Published: 13/08/2019

Additional Deliverable 12.3 Exposure model testing results

Published: 14/08/2019

Work package 13: Establishing exposure health relationships

WP13&14-joint-activities-LEADERS-and-PARTNERS

The file contains tables with contacts to LEADERS (Table 1) who should coordinate discussions within chemical groups and OTHER PARTNERS (Table 2) who contributes with relevant chemical expertise. Published: 04/05/2018

Deliverable 13.1 Criteria for the selection of cohort studies, June 2017

Published: 20/07/2017

Deliverable 13.2 Template for AOP update report for selected priority substances

Published: 29/06/2018

Deliverable 13.3 - Inventory of available samples and data collected from existing cohorts and preliminary results on exposure- response associations for 1st list of priority substances

Published: 27/02/2019

Deliverable 13.5 Identified gaps for the establishment of AOPs and required studies

Published: 09/07/2019

Work Package 14: Effect biomarkers

Deliverable 14.1 Criteria for prioritisation of biomarkers of effect

Published: 02/10/2017

Additional Deliverable 14.2 Granada Workshop: Effect biomarkers & establishing exposure and health relationships

Published: 08/08/2018

Deliverable 14.2 - List of effect biomarkers for the first set of prioritized substances, September 2018

Published: 02/10/2018

Deliverable 14.4 Report on results of the selected biomarkers of combined effect [Proof of concept]

Published: 15/11/2018

Additional Deliverable 14.4 First report on the state of development of new biomarkers of effect

Published: 28/01/2019

Deliverable 14.3 Report on available biomarkers of effect of utility in human epidemiological studies for the 1st set of prioritised substances

Published: 30/01/2019

Additional Deliverable 14.3 - WP14 - WP13 Interaction: Delineation of AOPs for the selection of effect biomarkers in the HBM4EU aligned studies Bisphenol A as a case-study

Published: 10/04/2019

Additional Deliverable 14.5 Report on the 2nd Granada Workshop: Implementing Effect Biomarkers

Published: 10/07/2019

Work package 15: Mixtures, HBM and human health risks

Additional Deliverable 15.3 HBM mixture database description and proposal statistical analysis plan

Published: 03/01/2018

Deliverable 15.3 Report real-life exposure profiles from re-analysis of existing HBM mixture data

Published: 28/01/2019

Additional Deliverable 15.1 Plan for development of case studies

Published: 21/03/2019

Deliverable 15.2 - Report Outline and workplan for the joint survey on HBM mixtures: an application to pesticide exposure in hotspots and control areas

Published: 16/05/2019

Work package 16: Emerging chemicals

Deliverable 16.1 Prioritised list of known emerging chemicals

Published: 03/01/2018

Additional Deliverable 16.1 Screening methods inventory

Published: 03/01/2018

Additional Deliverable 16.3 Direct effect based approaches applied to the screening of emerging substances

Published: 03/01/2018

Additional Deliverable 16.4 Emerging Substances

Published: 21/12/2018

Deliverable 16.2 Workflow for screening emerging chemicals

Published: 28/01/2019

Additional Deliverable 16.2 - Emerging chemicals framework

Published: 15/02/2019